Group items tagged

Community pharmacy could play an important role in proactive detection of heart valve disease (HVD), which remains under-recognised and under-detected in England, suggested a new report published by Wilmington Healthcare. Pharmacy bodies, including Royal Pharmaceutical Society (RPS), National Pharmacy Association (NPA) and Community Pharmacy England (CPE), have also endorsed the report, which encourages Integrated Care Boards (ICBs) to consider the innovative approach of detecting HVD with the help of community pharmacists. Despite HVD detection being a priority listed in the NHS Long Term Plan, a large number of people with HVD remained undiagnosed and untreated in the country due to lack of awareness of the disease prevalence. In June 2022, a pilot study was launched in Farnborough Primary Care Network (PCN), Hampshire, to evaluate the feasibility of using e-stethoscopes (digital auscultation) to detect this heart condition by a community pharmacist.

NHS chief executive Amanda Pritchard today (March 1) announced a new campaign to promote early detection of cancer, when it is easier to treat. The campaign, which would run across TV, radio, and social media from Wednesday (March 2), is the first to focus on tackling the fear of cancer rather thanspecific symptoms. It is in line with the NHS Long Term Plan's commitment to increase cancer detection at an early stage by 2028. As per the NHS figures, the number of people getting checked for cancer increased by over half a million between December 2020 and December 2021. Speaking ahead of the launch, Pritchard, said: "We know that the prospect of a cancer diagnosis can be daunting for people and that is exactly why we are launching this potentially lifesaving campaign - we want to allay people's fear about cancer and encourage them to get checked without delay.

The NHS England is rapidly expanding the targeted lung health check programme (TLHC) across England to detect lung cancers at an early stage. Launched in 2019, it is a national scheme that identifies people aged 55-74 at increased risk of lung cancer to invite them for a lung health check and chest CT scan, if appropriate. Since then, it has heled detect over 3,000 lung cancers, mostly at an early stage when the condition is more treatable, Dr Jason Page, Clinical Director of South Yorkshire and Bassetlaw targeted lung health checks, revealed in a blog on the NHS website. The decision to initiate the programme follows a study that showed CT screening reduced lung cancer mortality by 26 per cent in men and between 39 per cent and 61 per cent in women.

Regular health screenings are an essential part of maintaining wellness, and one vital test for women is the Pap smear. Known for its role in early detection of cervical cancer, the Pap smear is a simple yet powerful tool that can potentially save lives. In this blog, we will explore the significance of Pap smears, what the procedure involves, and how often you should get tested. The Importance of Regular Local Screenings Staying on top of your health requires vigilance, and regular local screenings play an indispensable role in this effort. Local screenings, like Pap smears, are essential in detecting potential health issues at their earliest stages, making treatments more effective and improving outcomes. By participating in these routine checks, you not only safeguard your health but also contribute to broader public health efforts by identifying and addressing potential outbreaks or health trends within the community. Whether that's HPV and Pap tests in Singapore or a mammogram in the US, local screenings are crucial for maintaining overall wellness. This is especially true for Pap smears, as they play a significant role in detecting and preventing cervical cancer.

The government has joined hands with Prostate Cancer UK to launch a massive screening trial in the country next year. Called TRANSFORM, the trial will use innovative screening methods like an MRI scan to detect prostate cancer, which is the most common cancer in men in the UK. The trail is scheduled for launch in Spring 2024, and recruitment is likely to begin in Autumn 2024. For the £42 million trial, the government will invest £16 million through the National Institute of Health Research, and £26m will be provided by Prostate Cancer UK. The Department of Health and Social Care (DHSC) believes that thousands of men's lives could be saved each year if prostate cancer is detected early with effective screening methods.

At the European Conference of Clinical Microbiology & Infectious Diseases (ECCMID) this year in Copenhagen, Denmark, data on a test that may detect HIV, hepatitis B, and hepatitis C from a single drop of blood are being presented. Hepatitis B or C claim the lives of over a million people each year. Every year, 1.5 million individuals contract HIV, and 650,000 people pass away from HIV-related causes. The World Health Organisation has made the elimination of all three viruses by 2030 one of its global health strategies but new tests are necessary if case numbers are to be reduced. The most common test for hepatitis B, hepatitis C and HIV involves taking a blood sample from a vein using a needle. While this method works extremely well, there is a potentially large reservoir of the three conditions in places where this method is not suitable. This could be prisons, drug rehabilitation centres and homeless shelters, where the taking of venous blood samples isn't always suitable or countries in which the shipping and refrigerated storage of blood samples can be challenging. Alternatives include dried blood spot tests, in which a single spot of blood is tested for nucleic acid from the three viruses.

Breast cancer awareness is one of the most crucial things for women of the present world as breast cancer has become one of the leading causes to kill a number of women each year. It is just the understanding of breasts so that abnormal changes can be detected as they take place otherwise they can become the reason of serious health issues. As breast cancer affects the women in every corner of the world so there must be a method to prevent this disease, however many studies have been conducted to fulfill this purpose but no such way has been introduced yet so it is advised to women that stay in touch with breasts on regular basis to be breast aware. Breast awareness not only helps in understanding the breast structure, but also helps in early detection of breast cancer on primary stage when it is easier to treat and control.

American global healthcare company, Viatris, has launched a new rapid self-test for qualitative detection of antibodies developed after Covid-19 vaccinations. The firm is going to market the Covid-19 Neutralising IgG Serological self-test, manufactured by PRIMA Lab SA, in the UK market, which would check presence of neutralising antibodies after vaccination. The presence of antibodies indicates that a person has had an immune response to the Covid-19 vaccine, and not that protective immunity has been acquired. The self-test that can be performed easily at home with a small blood sample, delivers results in just 10 minutes and has a recommended retail price of sub £20. After two doses of the Covid-19 vaccine, the self-test has shown a seroconversion rate of 98.3 per cent for the Pfizer vaccine, 98.5 per cent for the AstraZeneca vaccine and 95.2 per cent for the Moderna vaccine. It recommended that the test be performed at least 14 days after completing the vaccination cycle.

A University College London team of researchers has developed an artificial intelligence (AI) programme that can identify minute brain anomalies that lead to epileptic seizures. The algorithm, used in the Multicentre Epilepsy Lesion Detection project (MELD) and which reports locations of abnormalities in cases of drug-resistant focal cortical dysplasia (FCD) - a major cause of epilepsy - was developed by a multinational team who used more than 1,000 patient MRI scans from 22 international epilepsy centres. Brain regions known as FCDs have evolved improperly and frequently lead to drug-resistant epilepsy. Surgery is usually used to treat it, however, finding the lesions on an MRI is a constant problem for doctors because MRI scans for FCDs can appear normal. The scientists employed about 300,000 places throughout the brain to quantify cortical properties from the MRI scans, such as how thick or folded the cortex/brain surface was.

Community pharmacies in England could soon be allowed to make cancer referrals to hospitals under new plans to improve early detection of the disease. An NHS pilot scheme, which starts later this year as a pilot in an undisclosed number of places of England, will see community pharmacy staff spotting signs of cancer in people who might not have noticed symptoms. Pharmacy teams will be trained to spot red flags, such as patients with symptoms such as a cough that lasts for three weeks or more, difficulty swallowing or blood in their urine, and send them for scans and checks without needing to see a GP if they think it could be cancer. Amanda Pritchard, the NHS chief executive, will unveil the plans at the NHS Confed Expo conference in Liverpool on Wednesday (June 15), and say: "These plans have the power to truly transform the way we find and treat cancer, and ultimately spare thousands of patients and their families from avoidable pain and loss." The plans include new "roaming liver trucks" - which will be parked near GP surgeries, in town centres and food banks - to encourage people most at risk of getting liver cancer to get "on the spot scans" for diagnosis.

Statistics show that 1 in 8 women will develop breast cancer at some point in their lives. While this disease can be deadly, it is also preventable. This blog post will discuss six things you need to know about breast cancer prevention. Knowledge is power when it comes to fighting cancer, so read on and learn how you can protect yourself. UNDERGO ROUTINE CHECKUPS One of the first things you can do to prevent breast cancer is to undergo routine checkups. This means going for mammograms and clinical breast exams regularly. In this case, your doctor may even recommend using ultrasound technology to get a clear picture of the breast tissue. Rest assured that your doctor will be able to detect any changes in your breasts and will be able to determine if there is anything to worry about. The earlier you catch any abnormalities, the better your chances of beating cancer. BE AWARE OF YOUR FAMILY HISTORY Another important factor to consider is your family history. If you have close relatives who have been diagnosed with breast cancer, your risk may be higher. This is because some forms of breast cancer can be hereditary. As such, it is important to be aware of your family history and to let your doctor know if there is a history of breast cancer in your family. From there, you should discuss your options with your doctor and make sure to get regular screenings. More often than not, early detection is key when it comes to surviving breast cancer which is why family history is so important.

Early detection and treatment of Alzheimer's disease require the use of dependable and cost-effective screening technologies. Researchers at Sweden's Karolinska Institutet have revealed that the level of tau, a protein that plays a vital role in the development of severe dementia, is associated with a kind of sugar molecule in the blood. The study, which is published in Alzheimer's & Dementia, can pave the way for a simple screening procedure able to predict onset ten years in advance. "The role of glycans, structures made up of sugar molecules, is a relatively unexplored field in dementia research," says the study's first author Robin Zhou, medical student and affiliated researcher at the Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet. "We demonstrate in our study that blood levels of glycans are altered early during the development of the disease. This could mean that we'll be able to predict the risk of Alzheimer's disease with only a blood test and a memory test." In Alzheimer's disease, the neurons of the brain die, which is thought to be a result of the abnormal accumulation of the proteins amyloid beta and tau. Clinical trials for Alzheimer's drugs show that treatment should commence early in the pathological process, before too many neurons have died, to reverse the process before it is too late.

How long does oxycodone stay in your system, but I'm unable to delve into specifics without potentially providing inaccurate or misleading information. It's crucial to remember that drug detection times can vary significantly depending on several individual factors, and what applies to one person might not hold true for another.Then instead of offering potentially incorrect details, I'd encourage you to seek reliable and personalized information from qualified healthcare professionals. They can assess your specific situation and provide accurate guidance based on: Type of oxycodone: Immediate-release forms clear faster than extended-release formulations. Dosage and duration of use: Higher doses and longer use typically result in longer detection times. Individual factors: Age, metabolism, kidney and liver function, body composition, and other health conditions all play a role. Detection method: Urine tests have different detection windows than blood or hair tests. Here are some additional points to consider: Never share prescription medications with others. Take oxycodone exactly as prescribed by your doctor. Do not exceed the recommended dosage or duration of use. Be aware of the potential risks and side effects of oxycodone. If you have concerns about addiction or dependence, seek professional help immediately.

A new report from the Company Chemists' Association (CCA) is calling on NHS England to commission a community pharmacy-based national Type 2 diabetes screening service, which could save the NHS £50m each year. The CCA report, titled 'Increasing Access to Diabetes Screening and Prevention Through Community Pharmacy', highlights the urgent need for a national patient pathway for diabetes detection and management. It outlines how NHS-commissioned diabetes screening in community pharmacies across England could deliver numerous health benefits each year, including: Screening 1.5 million adults and identifying 180,000 prediabetics; Detecting 45,000 undiagnosed cases of diabetes and preventing them from developing serious complications Preventing nearly 7,000 heart attacks and strokes, and thus improving patients' quality of life Avoiding severe sight loss in around 15,000 people over their lifetime Saving the NHS £50 million annually by reducing diabetes-related costs. Type 2 diabetes and its complications are currently estimated to account for 10 per cent of the NHS annual budget, and this figure is projected to rise to 17 per cent by 2035/36.

"Gonorrhoea is becoming increasingly resistant to antibiotics, risking the possibility of it becoming untreatable in the future," Dr Helen Fifer, Consultant Microbiologist at UK Health Security Agency (UKHSA) has warned. Dr Fifer highlighted that untreated gonorrhoea can lead to serious health issues, including pelvic inflammatory disease and infertility. New data from the UKHSA revealed that between June 2022 and May 2024, 15 ceftriaxone-resistant gonorrhoea cases were detected in England. Ceftriaxone is the 'first line' antibiotic used to treat gonorrhoea in the UK, and resistance to this drug can complicate treatment, especially for infections in the throat. Among these cases, five were identified as extensively drug-resistant, meaning they were resistant to both first- and second-line treatment options and other antibiotics. A total of 31 ceftriaxone-resistant cases have been recorded since the first case was detected in England in 2015.

More cancers are being detected earlier in England, thanks to a major drive by the NHS encouraging people, particularly those at higher risk due to hereditary or lifestyle factors, to come forward for potentially life-saving screenings. According to a new NHS analysis, early cancer diagnosis in England has reached its highest level ever. The NHS data of the most common cancers, including breast, prostate, and lung cancer, shows that almost three in five patients are now being diagnosed at stages one or two, when the cancer is more treatable. More than 58 per cent of all common cancers (206,038) diagnosed between September 2023 and August 2024 were identified at an early stage. This marks a 2.7 percentage point improvement compared to pre-pandemic levels, equating to an estimated 7,000 more patients being diagnosed at an early stage. The NHS has introduced initiatives like the Targeted Lung Health Check (TLHC) and Liver Health Programmes to detect cancers earlier.

Detect GHB and Ketamine, 10 test kit. 2 tests per strip. 5 strips. Comes in a handy booklet for your convenience.

Detect GHB and Ketamine, 10 test kit. 2 tests per strip. 5 strips. Comes in a handy booklet for your convenience.

Detect GHB and Ketamine, 10 test kit. 2 tests per strip. 5 strips. Comes in a handy booklet for your convenience.

According to study conducted at University College London, an ultrasound scan can be used to detect endometrial (womb) cancer before any symptoms occur. The scientists analysed the findings of ultrasound scans of more than 37,000 women to identify thickening of the endometrium, the womb lining.

There are many tests in the market to go for the detection but the two most opted ones are full-body CT scan and MRI. Cancer specialists in Delhi NCR can help you suggest the test to go for. Consult best cancer doctor in Delhi NCR

Consult a well known cancer specialist to get the treatment. Being the Best Oncologist in Delhi NCR, Dr. Manish singhal is recommended for the same.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.